<DOC>
	<DOC>NCT01265147</DOC>
	<brief_summary>This phase II trial is studying cisplatin or nedaplatin combine with IMRT to evaluate which one is better efficacy and security in nasopharyngeal carcinoma.</brief_summary>
	<brief_title>Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Age≥18,T12aN13;T24NxNPC,VEGFR+,++,KPS＞70,Life expectancy≥6 months, No uncontrolled hypertension,cardiac failure,diabetes,lunacy Distant metastasis, recurrent disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>